NDC 0944-0495-06 - Flexbumin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0944-0495
- Requested NDC
- 0944-0495-06
- Package NDCs from labels
- 0944-0495-06, 0944-0495-05
- Manufacturer
- Takeda Pharmaceuticals America, Inc. | BAXALTA INCORPORATED | Baxalta US Inc.
- Effective date
- 2024-12-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Flexbumin | Takeda Pharmaceuticals America, Inc. | BAXALTA INCORPORATED | Baxalta US Inc. | 2024-12-18 | PLASMA DERIVATIVE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0944-0495-05 | Flexbumin | 2 in 1 CARTON | INJECTION, SOLUTION | 2 | 14 | |
| 0944-0495-06 | Flexbumin | 250 mL in 1 BAG | INJECTION, SOLUTION | 250 | 14 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0944-0495-05 | ML - Milliliter | 0944-0495 | e6b5163d-2d6e-48d4-82f5-00370a448dea | 1 | 2014-11-05 |
| 0944-0495-06 | ML - Milliliter | 0944-0495 | 73e9eb05-b979-44c1-b952-01d90fea11fb | 1 | 2024-01-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ALBUMIN HUMAN | ACTIVE INGREDIENT | ZIF514RVZR | FLEXBUMIN (ALBUMIN HUMAN) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 1 | |
| ALBUMIN HUMAN | ACTIVE MOIETY | ZIF514RVZR | FLEXBUMIN (ALBUMIN HUMAN) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 1 | |
| SODIUM ACETYLTRYPTOPHANATE | INACTIVE INGREDIENT | 3EN9H0M2FX | FLEXBUMIN (ALBUMIN HUMAN) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 1 | |
| SODIUM CAPRYLATE | INACTIVE INGREDIENT | 9XTM81VK2B | FLEXBUMIN (ALBUMIN HUMAN) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| WHWSWB 0.9% Saline | SODIUM CHLORIDE | Yiwu Huanshu E-commerce Co., Ltd | 4e9c21e5-f2f9-90e4-e063-6394a90acfe2 | 2026-07-11 | Warnings | LYR4M0NH37 |
| Spa/Pool Detox 6027 | SPA/POOL DETOX | Professional Complementary Health Formulas | 14b8fca2-089d-44f7-8b70-ee877c8f7af1 | 2026-01-08 | Warnings | LYR4M0NH37 |
| Radialgin 6002 | RADIALGIN | Professional Complementary Health Formulas | 5e7ce7a0-9f43-4a69-89e9-a59692a8de41 | 2026-01-08 | Warnings | LYR4M0NH37 |
| Proteinuria Drops 2053 | PROTEINURIA DROPS | Professional Complementary Health Formulas | 1bf80282-8283-4835-acd4-fbdb47788c67 | 2026-01-08 | Warnings | ZIF514RVZR |
| Sodium Acetate | SODIUM ACETATE | MILLA PHARMACEUTICALS INC. | 1ea1466d-a492-4056-e063-6394a90a80bf | 2026-01-07 | Warnings, Adverse reactions | 4550K0SC9B |
| Perikabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | c2eb5522-8572-45f4-869d-42f9fd251bb6 | 2025-09-15 | Warnings, Adverse reactions | 4550K0SC9B |
| Kabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | afeb4837-a759-4484-a76e-e04611c459e7 | 2025-09-11 | Warnings, Adverse reactions | 4550K0SC9B |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | 17dec820-1b57-4ac9-82a8-419cab664a2f | 2025-06-27 | Warnings, Adverse reactions | 4550K0SC9B |
| Sodium Acetate | SODIUM ACETATE | MILLA PHARMACEUTICALS INC. | 1ea04916-78e5-4651-e063-6394a90ac4be | 2025-01-16 | Warnings, Adverse reactions | 4550K0SC9B |
| ALBUMINEX | ALBUMIN HUMAN | BPL | 8428d373-f4b1-4e3b-bb19-ea89048f7c79 | 2024-12-31 | Warnings, Adverse reactions | ZIF514RVZR |
| ALBUMINEX | ALBUMIN HUMAN | BPL | 167f48d0-8ae5-4f7e-b050-9673dad78acc | 2024-12-31 | Warnings, Adverse reactions | ZIF514RVZR |
| Plasma-Lyte 148 (pH 7.4) | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE | Baxter Healthcare Corporation | fe935c8d-f42d-42e4-8665-0dc66829f231 | 2024-11-08 | 4550K0SC9B | |
| SODIUM ACETATE | SODIUM ACETATE | Fresenius Kabi USA, LLC | d7fabf08-d4e0-4bb5-8416-2e8ffe27c04b | 2024-10-11 | Warnings, Adverse reactions | 4550K0SC9B |
| Isolyte P in Dextrose | DEXTROSE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND POTASSIUM PHOSPHATE, DIBASIC | B. Braun Medical Inc. | 4ea4397c-2fa4-4670-91e6-21ae498c88f7 | 2024-06-24 | Warnings, Adverse reactions | 4550K0SC9B |
| Balanced Salt | SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, AND SODIUM CITRATE | B. Braun Medical Inc. | 74ab8883-0a5f-46b4-8998-9358f6fd4ef4 | 2024-03-13 | Warnings, Adverse reactions | 4550K0SC9B |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea | 2024-01-25 | Warnings, Adverse reactions | 4550K0SC9B |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 28488c7b-cf6a-4a03-916f-cc66b3afdc57 | 2023-12-14 | Warnings, Adverse reactions | 4550K0SC9B |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2023-10-06 | Warnings, Adverse reactions | 4550K0SC9B |
| Physiolyte | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 19c04dcb-d6f2-4624-afd4-1c7b7ddcb85e | 2023-09-26 | Warnings, Adverse reactions | 4550K0SC9B |
| Natrum Aceticum | NATRUM ACETICUM | Hahnemann Laboratories, INC. | 04cdea6c-8348-d855-e063-6294a90a6660 | 2023-09-07 | 4550K0SC9B |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.